Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Research funding program

  • Home
  • Data and research
  • Research funding program

Research Funding Program

Round 6 of the National Blood Sector Research and Development Program is now closed. Information about the Round 6 awarded grants will be published on Successful grant rounds page when finalised.

The National Blood Sector Research and Development Program (the Program) was established in 2015, as a nationally coordinated effort to address evidence gaps in the blood sector and respond to emerging evidence and new
technologies.

To date, we have run five rounds of the Program, funding 40 projects to the value of
just under $6 million (including GST).

Research under the program:

  • gathers knowledge and evidence about blood and blood products, and how to
    use them
  • informs good decisions for governments, patients, clinicians and others
  • supports best practices in managing and using blood and blood products and
    services

Through the program, we fund research on patient blood management and use of immunoglobulin.

The research helps to:

  • ensure the supply of blood products is sustainable and affordable
  • find appropriate uses for blood products
  • lessen the inappropriate use of blood products
  • maintain or improve clinical outcomes for patients.

Evaluation of the Program

In 2023, we conducted an evaluation of the Program to examine the Program's value for money, research translation, communication efforts, survivability, capacity building and collaboration. The following report outlines the significant benefits that the Program has had on the blood sector.

  • Evaluation of the National Blood Sector Research and Development Program.pdf
    4.07 MB

Criteria for applications

We use the Research and Development Strategic Priorities 2022–27 to provide guidance to applicants on the types of projects we are looking to fund.

This is to ensure we get the best outcomes for patients and deliver value for money for Australians.

When applying for funding, consider how your project:

  • optimises the use of blood and blood products
  • enhances supply, including product innovation and supply chain efficiencies
  • reduces donor and patient adverse events.

You should also consider the key enabling factors, including:

  • improving data collection, accuracy and sharing
  • optimising health service delivery to best meet patient needs
  • strengthening workforce capability.

National Blood Research and Development Strategic Priorities

Applying for funding

When we open a round for funding, we'll invite you to apply for:

  • project grants
  • seed grants
  • scholarships.

You will find the following application information on GrantConnect(Opens in a new tab/window):

  • grant opportunity guidelines
  • application forms
  • grant funding agreement
  • letter of agreement

     

Past funding rounds

We've published details and recipients of past funding rounds.

GrantConnect also lists funding round outcomes(Opens in a new tab/window) since Round 4.

 

With the evaluation complete we will look at opening the next round in the near future

Get in touch

Email: research@blood.gov.au.

Last updated: 29 May 2025

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback